Alerts will be sent to your verified email
Verify EmailSOLARA
|
Solara Active Pharma
|
Morepen Laboratories
|
Hester Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Manufacturing Capacity - Ibuprofen
|
5000.0 MTPA | n/a | n/a |
|
US DMF Filings
|
230.0 . | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
2.8 % | 13.43 % | 11.06 % |
|
5yr average Equity Multiplier
|
1.99 | 1.68 | 2.16 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 1.29 | 0.45 |
|
5yr Avg Net Profit Margin
|
-7.28 % | 5.93 % | 11.7 % |
|
Price to Book
|
2.22 | 2.67 | 5.75 |
|
P/E
|
0.0 | 35.12 | 37.25 |
|
5yr Avg Cash Conversion Cycle
|
28.67 Days | 12.78 Days | 50.33 Days |
|
Inventory Days
|
111.94 Days | 54.64 Days | 95.01 Days |
|
Days Receivable
|
95.97 Days | 65.45 Days | 92.43 Days |
|
Days Payable
|
146.85 Days | 96.29 Days | 116.74 Days |
|
5yr Average Interest Coverage Ratio
|
0.25 | 39.11 | 6.83 |
|
5yr Avg ROCE
|
2.1 % | 15.77 % | 10.65 % |
|
5yr Avg Operating Profit Margin
|
9.63 % | 8.68 % | 21.24 % |
|
5 yr average Debt to Equity
|
0.7 | 0.04 | 0.76 |
|
5yr CAGR Net Profit
|
-69.98 % | 3.98 % | 7.19 % |
|
5yr Average Return on Assets
|
-3.67 % | 7.67 % | 5.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.0 % | 35.65 % | 53.73 % |
|
Share Pledged by Promoters
|
31.57 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.03 % | -2.57 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.03 % | 0.0 | 0.0 |
|
Solara Active Pharma
|
Morepen Laboratories
|
Hester Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|